首页|期刊导航|实用肝脏病杂志|PTGD术后LC手术治疗急性重症胆囊炎患者时机选择探讨

PTGD术后LC手术治疗急性重症胆囊炎患者时机选择探讨OA

Optimal timing of laparoscopic cholecystectomy after percutaneous transhepatic gallbladder drainage in the treatment of patients with acute severe cholecystitis

中文摘要英文摘要

目的 探讨经皮经肝胆囊穿刺引流术(PTGD)后腹腔镜胆囊切除术(LC)治疗急性重症胆囊炎(ASC)患者的最佳手术时机.方法 2022年1月~2025年3月我院收治的ASC患者45例,均采用急诊PTGD治疗.在采用LC手术时,将患者分为A组20例,于PTGD术后50天内行LC治疗,和B组25例,于PTGD术70天后行LC治疗.采用ELISA法检测血清白细胞介素(IL)-6和C反应蛋白(CRP)水平.结果 B组LC手术时间、术后首次排气时间、术中出血量和住院日分别为(81.2±9.5)min、(21.6±4.0)h、(67.3±8.2)mL 和(4.4±1.3)d,均显著短(少)于 A 组[分别为(93.4±10.6)min、(28.7±5.1)h、(87.5±9.3)mL 和(6.6±1.7)d,P<0.05];在LC术前,B 组血清 TBIL、ALT 和 AST 水平分别为(27.4±3.5)μmol/L、(65.1±7.0)U/L 和(54.2±10.7)U/L,均显著低于 A 组[分别为(46.7±3.8)μmol/L、(94.5±6.3)U/L、(83.6±10.2)U/L,P<0.05];B 组血清 IL-6、CRP 和外周血 WBC 计数分别为(15.1±5.3)pg/mL、(9.6±2.4)mg/L 和(8.9±1.6)× 109/L,均显著低于 A 组[分别为(34.8±4.6)pg/mL、(19.3±2.1)mg/L 和(13.6±3.2)×109/L,P<0.05];B 组 LC 术后并发症发生率为12.0%,显著低于A组的30.0%(P<0.05).结论 在PTGD术2个月后行LC术治疗ASC患者更具优势,可有效缩短手术时间,减少并发症的发生,可能与机体炎性反应已经很好地消退有关.

Objective The aim of this study was to investigate the perfect timing of laparoscopic cholecystectomy(LC)after percutaneous transhepatic gallbladder drainage(PTGD)in the treatment of patients with acute severe cholecystitis(ASC).Methods 45 patients with ASC were admitted to our hospital between January 2022 and March 2025,and all underwent emergent PTGD for amelioration of acute body inflammatory reaction.For LC,patients were randomly assigned to have the operation within 50 days after PTGD in 20 cases(group A)or 70 days after PTGD in 25 cases(group B).Serum interleukin(IL)-6 and C-reactive protein(CRP)levels were detected by ELISA.Results The operation time of LC,postoperative first exhaust time,intraoperative blood loss and hospital stay after surgery in group B were(81.2±9.5)min,(21.6±4.0)h,(67.3±8.2)mL and(4.4±1.3)d,all significantly shorter or less than[(93.4±10.6)min,(28.7±5.1)h,(87.5±9.3)mL and(6.6±1.7)d,respectively,P<0.05]in group A;at admission for LC,serum bilirubin,ALT and AST levels in group B were(27.4±3.5)μmol/L,(65.1±7.0)U/L and(54.2±10.7)U/L,all much lower than[(46.7±3.8)μmol/L,(94.5±6.3)U/L and(83.6±10.2)U/L,respectively,P<0.05]in group A;serum IL-6,CRP levels and white blood cell count in group B were(15.1±5.3)pg/mL,(9.6±2.4)mg/Land(8.9±1.6)×109/L,all significantly lower than[(34.8±4.6)pg/mL,(19.3±2.1)mg/L and(13.6±3.2)×109/L,respectively,P<0.05]in group A;incidence of adverse effects after LC in group B was 12.0%,much lower than 30.0%(P<0.05)in group A.Conclusion Timing of LC 2 months after PTGD has more advantages in the treatment of patients with ASC,which could shorten operation time,with less post-operational complications,and might be related to alleviation of body inflammatory reaction.

王颖;曾剑萍;殷贵强;温希;贺凯

646000 四川省泸州市 西南医科大学附属医院手术室646000 四川省泸州市 西南医科大学附属医院手术室646000 四川省泸州市 西南医科大学附属医院手术室646000 四川省泸州市 西南医科大学附属医院手术室646000 四川省泸州市 西南医科大学附属医院肝胆外科

急性重症胆囊炎经皮经肝胆囊穿刺引流术腹腔镜胆囊切除术手术时机治疗

Acute severe cholecystitisPercutaneous transhepatic gallbladder drainageLaparoscopic cholecystectomySurgical timingTherapy

《实用肝脏病杂志》 2026 (1)

149-152,4

四川省卫健委科研项目(编号:19PJ581)

10.3969/j.issn.1672-5069.2026.01.038

评论